Innate Pharma appoints two new board members
Yannis Morel, currently Executive Vice President, Product Strategy and Business Development, and member of the Board, is promoted to Executive Vice President, Chief Operating Officer, adding research and early development to his responsibilities.
As previously announced, Hervé Brailly has been acting Chairman of the Board since January 1, 2024, pending a permanent successor to this position. Co-founder of Innate Pharma, he was formerly Chairman of the Supervisory Board.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction